Literature DB >> 26820641

Specificity and impact of adrenergic projections to the midbrain dopamine system.

Carlos A Mejias-Aponte1.   

Abstract

Dopamine (DA) is a neuromodulator that regulates different brain circuits involved in cognitive functions, motor coordination, and emotions. Dysregulation of DA is associated with many neurological and psychiatric disorders such as Parkinson's disease and substance abuse. Several lines of research have shown that the midbrain DA system is regulated by the central adrenergic system. This review focuses on adrenergic interactions with midbrain DA neurons. It discusses the current neuroanatomy including source of adrenergic innervation, type of synapses, and adrenoceptors expression. It also discusses adrenergic regulation of DA cell activity and neurotransmitter release. Finally, it reviews several neurological and psychiatric disorders where changes in adrenergic system are associated with dysregulation of the midbrain DA system. This article is part of a Special Issue entitled SI: Noradrenergic System.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Addiction; Anatomy; Dopamine; Norepinephrine; Physiology; Prefrontal cortex

Mesh:

Substances:

Year:  2016        PMID: 26820641      PMCID: PMC4879068          DOI: 10.1016/j.brainres.2016.01.036

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  149 in total

Review 1.  Treatment of attention-deficit-hyperactivity disorder.

Authors:  J Elia; P J Ambrosini; J L Rapoport
Journal:  N Engl J Med       Date:  1999-03-11       Impact factor: 91.245

2.  Alpha2-adrenoceptor activation increases a cationic conductance and spontaneous GABAergic synaptic activity in dopaminergic neurones of the rat substantia nigra.

Authors:  L Cathala; A Guyon; D Eugene; D Paupardin-Tritsch
Journal:  Neuroscience       Date:  2002       Impact factor: 3.590

3.  Effects of locus coeruleus lesions on the release of endogenous dopamine in the rat nucleus accumbens and caudate nucleus as determined by intracerebral microdialysis.

Authors:  A J Lategan; M R Marien; F C Colpaert
Journal:  Brain Res       Date:  1990-07-16       Impact factor: 3.252

4.  Dual effects of D-amphetamine on dopamine neurons mediated by dopamine and nondopamine receptors.

Authors:  W X Shi; C L Pun; X X Zhang; M D Jones; B S Bunney
Journal:  J Neurosci       Date:  2000-05-01       Impact factor: 6.167

5.  Clonidine modulates dopamine cell firing in rat ventral tegmental area.

Authors:  J Grenhoff; T H Svensson
Journal:  Eur J Pharmacol       Date:  1989-06-08       Impact factor: 4.432

6.  Glutamatergic and nonglutamatergic neurons of the ventral tegmental area establish local synaptic contacts with dopaminergic and nondopaminergic neurons.

Authors:  Alice Dobi; Elyssa B Margolis; Hui-Ling Wang; Brandon K Harvey; Marisela Morales
Journal:  J Neurosci       Date:  2010-01-06       Impact factor: 6.167

7.  The alpha(2) adrenoceptor antagonist idazoxan alleviates L-DOPA-induced dyskinesia by reduction of striatal dopamine levels: an in vivo microdialysis study in 6-hydroxydopamine-lesioned rats.

Authors:  Kerstin Buck; Patrizia Voehringer; Boris Ferger
Journal:  J Neurochem       Date:  2009-11-06       Impact factor: 5.372

8.  Excitatory drive onto dopaminergic neurons in the rostral linear nucleus is enhanced by norepinephrine in an α1 adrenergic receptor-dependent manner.

Authors:  Megan A Williams; Chia Li; Thomas L Kash; Robert T Matthews; Danny G Winder
Journal:  Neuropharmacology       Date:  2014-07-10       Impact factor: 5.250

9.  Evidence that the acute behavioral and electrophysiological effects of bupropion (Wellbutrin) are mediated by a noradrenergic mechanism.

Authors:  B R Cooper; C M Wang; R F Cox; R Norton; V Shea; R M Ferris
Journal:  Neuropsychopharmacology       Date:  1994-10       Impact factor: 7.853

Review 10.  Behavioral dopamine signals.

Authors:  Wolfram Schultz
Journal:  Trends Neurosci       Date:  2007-04-02       Impact factor: 13.837

View more
  13 in total

1.  ABO blood groups and psychiatric disorders: a Croatian study.

Authors:  Sandra Vuk Pisk; Tomislav Vuk; Ena Ivezić; Irena Jukić; Jasna Bingulac-Popović; Igor Filipčić
Journal:  Blood Transfus       Date:  2018-02-15       Impact factor: 3.443

Review 2.  Noradrenergic Modulation on Dopaminergic Neurons.

Authors:  Meng-Yang Zhu
Journal:  Neurotox Res       Date:  2018-03-23       Impact factor: 3.911

Review 3.  Behavioral, neurobiological, and neurochemical mechanisms of ethanol self-administration: A translational review.

Authors:  Ashley A Vena; Shannon L Zandy; Roberto U Cofresí; Rueben A Gonzales
Journal:  Pharmacol Ther       Date:  2020-05-11       Impact factor: 12.310

4.  Neurokinin-1 Antagonism Distinguishes the Role of Norepinephrine Transporter from Dopamine Transporter in Mediating Amphetamine Behaviors.

Authors:  Padmanabhan Mannangatti; Durairaj Ragu Varman; Sammanda Ramamoorthy; Lankupalle D Jayanthi
Journal:  Pharmacology       Date:  2021-09-02       Impact factor: 3.429

Review 5.  Parkinson's Disease: From Pathogenesis to Pharmacogenomics.

Authors:  Ramón Cacabelos
Journal:  Int J Mol Sci       Date:  2017-03-04       Impact factor: 5.923

6.  Stimulation of noradrenergic transmission by reboxetine is beneficial for a mouse model of progressive parkinsonism.

Authors:  Grzegorz Kreiner; Katarzyna Rafa-Zabłocka; Justyna Barut; Piotr Chmielarz; Marta Kot; Monika Bagińska; Rosanna Parlato; Władysława Anna Daniel; Irena Nalepa
Journal:  Sci Rep       Date:  2019-03-27       Impact factor: 4.379

7.  Gαq protein signaling in the bed nucleus of the stria terminalis regulate the lipopolysaccharide-induced despair-like behavior in mice.

Authors:  Nao Fukuwada; Miki Kanno; Satomi Yoshida; Kenjiro Seki
Journal:  AIMS Neurosci       Date:  2020-11-10

Review 8.  Linking Ethanol-Addictive Behaviors With Brain Catecholamines: Release Pattern Matters.

Authors:  Vladimir P Grinevich; Evgeny M Krupitsky; Raul R Gainetdinov; Evgeny A Budygin
Journal:  Front Behav Neurosci       Date:  2021-12-16       Impact factor: 3.558

9.  Noradrenergic deficits contribute to apathy in Parkinson's disease through the precision of expected outcomes.

Authors:  Frank H Hezemans; Noham Wolpe; Claire O'Callaghan; Rong Ye; Catarina Rua; P Simon Jones; Alexander G Murley; Negin Holland; Ralf Regenthal; Kamen A Tsvetanov; Roger A Barker; Caroline H Williams-Gray; Trevor W Robbins; Luca Passamonti; James B Rowe
Journal:  PLoS Comput Biol       Date:  2022-05-09       Impact factor: 4.779

Review 10.  Locus coeruleus-norepinephrine: basic functions and insights into Parkinson's disease.

Authors:  Bilal Abdul Bari; Varun Chokshi; Katharina Schmidt
Journal:  Neural Regen Res       Date:  2020-06       Impact factor: 5.135

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.